MedTrace Logo

Telehealth-Delivered Gut-Directed Hypnotherapy for Managing GI Health

NCT06890663 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2025-11-04

No results posted yet for this study

Summary

This study aims to evaluate the specific and non-specific effects of hypnotherapy and to evaluate the efficacy of group-format gut-directed hypnotherapy (GDH) delivered via telehealth for managing gastrointestinal health.

Conditions

  • Gastrointestinal Disease
  • Gastrointestinal Disorders
  • Nervous System

Interventions

OTHER

Nonspecific Hypnotherapy for Relaxation

A therapeutic technique that uses hypnosis for relaxation.

OTHER

Gut-Directed Hypnotherapy (GDH)

A therapeutic technique that uses hypnosis and relaxation to help with gastrointestinal (GI) disorders.

OTHER

3-month Follow-Up

A 3-month follow is completed after both intervention phases (general hypnotherapy and Gut Directed Hypnotherapy) are completed for each participant.

Sponsors & Collaborators

  • University of Central Florida

    lead OTHER

Principal Investigators

  • Jeffrey Cassisi, PhD · University of Central Florida

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-19
Primary Completion
2025-10-30
Completion
2025-10-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06890663 on ClinicalTrials.gov